FDA Approves Unknown Drug — STRIDES PHARMA INTL

Strides Pharma International has received approval from the U.S. Food and Drug Administration (FDA) for ANDA No. 078783, likely signaling the green light for a generic entry into the U.S. market. The anticipated approval is expected to enhance the company’s revenue streams through commercial sales while intensifying competitive pressure on the branded formulation in the sector.